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Escherichia coli produces polysaccharide capsules that, based on their mechanisms of synthesis and assem-
bly, have been classified into four groups. The group 4 capsule (G4C) polysaccharide is frequently identical to
that of the cognate lipopolysaccharide O side chain and has, therefore, also been termed the O-antigen capsule.
The genes involved in the assembly of the group 1, 2, and 3 capsules have been described, but those required
for G4C assembly remained obscure. We found that enteropathogenic E. coli (EPEC) produces G4C, and we
identified an operon containing seven genes, ymcD, ymcC, ymcB, ymcA, yccZ, etp, and etk, which are required for
formation of the capsule. The encoded proteins appear to constitute a polysaccharide secretion system. The
G4C operon is absent from the genomes of enteroaggregative E. coli and uropathogenic E. coli. E. coli K-12
contains the G4C operon but does not express it, because of the presence of IS1 at its promoter region. In
contrast, EPEC, enterohemorrhagic E. coli, and Shigella species possess an intact G4C operon.
Escherichia coli strains exhibit variations in their cell surface
polysaccharides. The primary surface polysaccharides, lipo-
polysaccharide (LPS) and capsule, are serotype specific (28,
33). Based on their mechanisms of synthesis and assembly, the
E. coli capsules have been classified into four groups (33).
Since in some cases the polysaccharide of the group 4 capsule
(G4C) is identical to that of the cognate LPS O side chain,
G4C was also termed O-antigen capsule (13). E. coli O111 and
O127, serotypes which are typical also of enteropathogenic E.
coli (EPEC) and enterohemorrhagic E. coli, were reported to
form G4C (13, 27). The specific genes required for the assem-
bly of group 1, 2, and 3 capsules have been identified and
characterized (33). However, until now, the genes necessary
for the assembly of the G4C were not known.
LPS is an amphipathic glycoconjugate whose hydrophobic do-
main, lipid A, forms the outer leaflet of the outer membrane. The
core oligosaccharide links lipid A to the oligosaccharide side
chain, known as the O antigen. The structure of lipid A and of the
core oligosaccharide is conserved, but the structure of the O
antigen is variable (28). The E. coli O antigen may be synthesized
by several alternative mechanisms, including the Wzy-dependent
pathway. The O antigen, which is synthesized via the Wzy-depen-
dent pathway, is made up of repeat units typically consisting of
three to five sugar residues (28). The structural diversity of the O
antigens stems mainly from variations in sugar composition, se-
quence, and linkage. Synthesis and assembly of LPS require nu-
merous proteins, which are encoded by genes clustered in three
loci (28): the lipid A biosynthesis region, the core oligosaccharide
synthesis locus, and the O-antigen synthesis locus. Lipid A linked
to the core oligosaccharide is assembled on the inner leaflet of the
plasma membrane and then translocated to the outer leaflet. The
O-antigen repeat unit is also synthesized on the inner leaflet of
the plasma membrane, on a lipid carrier (undecaprenol phos-
phate, und-PP). Und-PP, linked to repeat units, is then translo-
cated to the outer leaflet of the plasma membrane (28). Trans-
location of the individual und-PP-linked O units to the periplasm
requires Wzx, the O-unit transporter (“flippase”) (23). The und-
PP-linked O units are polymerized on the periplasmic face of the
plasma membrane. The reaction involves transfer of the nascent
polymer from its und-PP carrier to the nonreducing end of the
new und-PP-linked O repeat. The net effect is a chain-length
increase by 1 repeat unit. Polymerization is catalyzed by the O-
polysaccharide polymerase Wzy (2), an integral membrane pro-
tein exhibiting specificity for the cognate O unit. The polymerized
O antigen is then ligated to the core oligosaccharide. WaaL, an
integral membrane protein, is required for this process (28).
Upon ligation of the O side chain, the complete LPS is translo-
cated to the external leaflet of the outer membrane.
Polymerization of G4C polysaccharide is also dependent on
the O-antigen polymerase Wzy (1, 32). However, in contrast to
LPS, G4Cs are composed of a high-molecular-weight polysac-
charide attached to the bacterial surface not via lipid but prob-
ably by interaction with a specific surface protein(s) (29). We
previously showed that EPEC O127:H6 expresses the etk gene,
which encodes a protein tyrosine kinase (17). We now report
that etk is encoded within an operon containing six additional
genes and that the products of each of these genes are required
for the assembly of G4C. The G4C operon appears to encode
* Corresponding author. Mailing address: Department of Molecular
Genetics and Biotechnology, Faculty of Medicine, The Hebrew Uni-
versity, POB 12272, Jerusalem 91120, Israel. Phone: 972 2 6758754.
Fax: 972 2 6757308. E-mail: ilanro@cc.huji.ac.il.
† Y. Shifrin and A. Peleg contributed equally to this study.
5259
components of a polysaccharide secretion and capsule assem-
bly apparatus. This operon was found in E. coli K-12, but it is
not expressed. It is also present in a specific subset of E. coli
and Shigella sp. strains.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and
plasmids used in this study are listed in Table 1. The primers
are listed in Table 2.
Construction of mutants. The Lambda Red system was used
to replace the wild-type alleles with inactivated genes. To in-
activate etk, the kan cassette of pUC4Kan (Pharmacia) was
inserted into the BglII site of etk cloned in pQE31 (pOI194),
resulting in the plasmid pOIK. The etk::kan gene was then
amplified and used to replace the wild-type allele. Most of the
coding regions of etp, ymcA, ymcB, ymcC, ymcD, and yccZ were
replaced with a kan or chloramphenicol (Cm) cassette, ampli-
fied from pKD3 or pKD4, respectively. Similarly, the promoter
region of the colanic acid (CA) operon and wza, the first gene
of the operon, were deleted and replaced with a kan cassette.
To construct a mutant containing a polar cassette downstream
of the G4C promoter, the ymcD coding region was cloned into
the pir-dependent suicide vector pGP704 (25), to give
pAP2125. The plasmid was then mobilized into EPEC (Strr) by
conjugation from E. coli SM10 pir. Transconjugants contain-
ing chromosomally integrated plasmid were selected on plates
containing ampicillin (50 g/ml) and streptomycin (100 g/
ml). Plasmid integration via homologous recombination be-
tween the ymcD alleles was confirmed by PCR.
Plasmid construction. A SalI fragment from pNDMI1 car-
rying lacIq was cloned into the SalI site of pACYC184, gener-
ating pACYC234. The SalI site distal to the HindIII site was
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference or source
Non-EPEC strains
MC4100 F araD139 (argF-lac)U169 rpsL150 relA1 flbB5301 deoC1 pstF25 rbsR] S. Altuvia
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F priAB lacIqZM15 Tn10(Tetr)] Stratagene
XL2-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F priAB lacIqZM15 Tn10(Tetr)
Amy Camr]
Stratagene
SY327 pir Permissive host for transformation M. Donnenberg
SM10 pir Permissive host for conjugation M. Donnenberg
EPEC strains
E2348/69 Wild-type EPEC O127:H6 22
OI899 E2348/69 etk::kan This study
AD1104 E2348/69 etp::cm This study
AD2417 E2348/69 etp::kan This study
AD1661 E2348/69 yccZ::kan This study
AD1596 E2348/69 ymcA::kan This study
AD1663 E2348/69 ymcB::kan This study
AD1963 E2348/69 ymcC::kan This study
AD1691 E2348/69 ymcD::kan This study
AD2119 E2348/69 ymcD::pAP2125 This study
MS1651 E2348/69 Pcps::kan This study
SN40 E2348/69 ymcA::mini-Tn10kan This study
Plasmids
pQE31 Expression vector Qiagen
pGEM-T Cloning vector Promega
pACYC184 Cloning vector New England Biolabs
pSA10 Expression vector containing lacIq 30
pKD3 Template for amplification of Cm cassette 5
pKD4 Template for amplification of Kan cassette 5
pKD13 Template for amplification of Kan cassette 5
pKD46 Helper plasmid expressing  Red genes 5
pNDMI1 Containing lacI on SalI fragment S. Altuvia
pOI194 etk cloned in pQE31 17
pUC4Kan Containing kan cassette Pharmacia
pOI277 pACYC expressing etk 17
pAP406 etp cloned in pQE31 This study
pAP2064 etp cloned in pSA10 This study
pAP1710 ymcA cloned in pSA10 This study
pAP1720 ymcB cloned in pSA10 This study
pAP1711 ymcC cloned in pSA10 This study
pAP1712 ymcD cloned in pSA10 This study
pAP1713 yccZ cloned in pSA10 This study
pOI231 pOI194 containing kan cassette in the BamHI site of etk This study
pGP704 Suicide vector 25
pAP2125 ymcD cloned in pGP704 This study
pAP2133 ymcD-cspH intergenic region cloned in pGEM-T This study
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disrupted. The pOI194 plasmid was digested with XhoI and
HindIII. The fragment containing 6his-etk under the tac pro-
moter was cloned into the SalI and HindIII sites of
pACYC234, giving rise to pOI277, which expresses 6His-Etk.
The ymcA, ymcB, ymcC, ymcD, and yccZ genes were amplified
with primers fitted with suitable restriction sites and encoding
six additional His residues at the 3 end of the genes (Table 1)
and cloned into the pSA10 expression vector digested with
EcoRI and PstI or SalI. The etp gene was amplified and cloned
in pSA10 as described above (to generate pAP2064) or in
pQE31 to generate pAP406, which encodes 6his-etp. The prim-
ers which were used are listed in Table 2.
Agglutination assay. Bacteria were grown overnight in LB
without NaCl, and when needed 0.1 mM IPTG (isopropyl--
D-thiogalactopyranoside) was added. The bacteria then re-
mained untreated or were heated to 100°C for 2 min and
cooled for 1 h at room temperature. Twofold dilutions of
anti-O antiserum in phosphate-buffered saline were prepared,
and 50 l of each dilution was added to 50 l of heated and
unheated bacteria in 96-well plates. The plates were then in-
cubated overnight at 50°C and examined for bacterial aggluti-
nation.
Electron microscopy. Bacteria grown overnight in LB at
37°C were washed with 0.1 M cacodylate buffer, pH 7.0; labeled
with cationized ferritin (2 mg/ml; Sigma) for 30 min; and fixed
with 5% glutaraldehyde for 1 h at room temperature (21). Fixed
samples were washed, postfixed with 1% osmium tetroxide for 2 h
at room temperature, dehydrated in a graded series of ethanol
solutions, and embedded in Epon resin. Thin sections were
stained with 2% uranyl acetate and lead citrate and examined
TABLE 2. Oligonucleotide primers (in 5-3 orientation) used for PCR
Primer and use Sequencea
Gene inactivation




ymcC KO F ................GTGCGCCCTCTTATTTTATCGATTTTCGCACTATTTCTTGCGGGATGTACGTGAgtgtaggctggagctgcttcg
ymcC KO R................TCATGGTGCGGGTTTAAGAAACGTCATTTCTACGGGAATAACCCCTGCGCCcatatgaatatcctccttag
ymcD KO F ................GCTGCGTTTGCTGCCCCTGAAGCAACAAACGGGACCGAGGCAACGACGGGTgtgtaggctggagctgcttc
ymcD KO R ...............AACAACTGCCAACGTCGCCACACCAACAGCCGTTGCCACACCGAAACcatatgaatatcctccttag
yccZ KO F..................ACCCTTGTTCCTGGTCAGAATTTATCGACCAGTAACAAGGATGTCATTgtgtaggctggagctgcttc
yccZ KO R .................CGGTACCAGCAGAGAAATCACACGGTTCCAACGAGCCAGCGGCGCGGTcatatgaatatcctccttag
Etk KO F....................ACCGTCAATGGTATGGTC
Etk KO R ...................CGTTTTACCACTGTCTGG
Etp KO F....................GTTTGTACCGGCAACATTTGCCGTTCGCCCATTGGCGAGCGCTTGCTGCGTTgtgtaggctggagctgcttc






























a For gene inactivation primers, sequences complementing the resistance cassette are in lowercase; for cloning primers, sequences encoding 6His are underlined and
stop codons are in boldface.
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under a JEOL 1200EX transmission electron microscope oper-
ating at 80 kV. To quantify capsule expression, low-power micro-
graphs were recorded and the percentage of bacteria express-
ing cationized ferritin staining material was determined.
Buoyancy assay. Bacterial strains were grown without shak-
ing in 5 ml LB to an optical density at 600 nm (OD600) of 0.3
at 37°C in transparent tubes. The medium was underlaid with
2 ml Percoll (55% Percoll [Amersham], 25 mM phosphate
buffer, pH 6.5) and centrifuged in an Eppendorf 5403 centri-
fuge swing bucket rotor at 1,000  g at room temperature for
20 min. The wild-type encapsulated EPEC cells formed a band
at the Percoll-medium interface, and the noncapsulated strains
formed pellets.
Preparation of total cellular polysaccharide. Bacteria were
grown overnight in 50 ml LB without NaCl. The OD of the
cultures was adjusted to 1.0, and the cultures were centrifuged
and resuspended in 500 l of phosphate-buffered saline. An
equal volume of saturated phenol (pH 8.0) was added, and the
mixture was incubated for 30 min at 70°C with occasional
mixing followed by centrifugation (1 h, 10,000  g). The top,
aqueous phase was recovered, 2 volumes of 100% ethanol was
added to each sample, and the polysaccharides were allowed to
precipitate for 1 h at 70°C. The samples were centrifuged at
12,000  g for 30 min, and the pellets were washed with 500 l
of 70% ethanol, recentrifuged, and lyophilized.
Separation of capsule polysaccharide from LPS. The lyoph-
ilized total polysaccharide preparations were resuspended in
500 l of water. The resuspended LPS, which formed micelles,
was precipitated by ultracentrifugation (1 h, 86,000  g) (27).
The supernatant containing the capsule polysaccharide was
recovered, and residual LPS contamination was removed by
phase partition with Triton X-114 as described previously (24).
Briefly, Triton X-114 was added to the supernatant to a final
concentration of 1%. The mixture was incubated at 4°C for 1 h
with constant stirring to ensure a homogenous solution. The
mixture was then transferred to a 37°C water bath, incubated
for 10 min, and centrifuged (1 h, 1,000  g) at 25°C. The
resulting aqueous phase containing purified capsule polysac-
charide was carefully aspirated. We confirmed that the prep-
aration was LPS free by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and Western analysis using
anti-O127 (data not shown).
Analysis of LPS and capsule polysaccharide. Total cell poly-
saccharide was separated on 10% polyacrylamide gels contain-
ing 0.5% SDS (SDS-PAGE), and the gels were used for im-
munoblot analysis. The SDS-PAGE gels allowed visualization
of the LPS without the interference of capsular polysaccharide,
which cannot enter the gel because of its low net charge and
high molecular weight (13, 27). Samples containing purified
capsule polysaccharide were applied directly to nitrocellulose
membranes for dot blot analysis. Blots were developed with
anti-O127 monospecific rabbit antiserum (Statens Serum In-
stitut, Denmark) and secondary anti-rabbit immunoglobulin G
conjugated to alkaline phosphatase (Sigma).
Complement sensitivity assay. Blood was taken from
healthy subjects after receiving their informed consent. The
blood was left to clot at 37°C for 45 min, and the serum was
separated from the clot by centrifugation (10 min, 700  g).
Aliquots containing 0.2 ml of bacterial culture in early log
phase (OD600 of 0.2) were mixed with 0.6 ml serum and incu-
bated at 37°C. Samples of 0.1 ml were diluted and plated for
viable count at different time points. Complement was inacti-
vated by incubating the serum for 20 min at 56°C before mixing
it with the bacterial culture.
Transposon mutagenesis and isolation of noncapsulated
mutant. Transposon mutagenesis with mini-Tn10kan was car-
ried out as described previously (6). Mutants deficient in cap-
sule formation were isolated as pellet-forming bacteria in the
Percoll buoyancy assay.
RNA analysis. Primer extension assays were carried out as
described previously (10). Briefly, bacterial cultures grown to
an OD600 of 0.3 or 1.0 were pelleted and resuspended in 10
mM Tris, pH 7.5, and 1 mM EDTA. Lysozyme was added to
0.9 mg/ml, and the samples were subjected to three freeze-
thaw cycles. Total RNA was isolated using an Ultraspec RNA
kit according to the manufacturer’s (BIOTECX Laboratories)
instructions, except that 1 ml of reagent was used for 12 to 16
OD600 units of cells. The RNA samples (3 g) were subjected
to primer extension at 42°C for 45 min, using avian myeloblas-
tosis virus reverse transcriptase (CHIMWEx) and end-labeled
primer 828. The extension products and the sequencing reac-
tion mixtures primed with end-labeled primer 828 were sepa-
rated on a 6% sequencing gel.
Genome comparison. We used the coliBASE server (http:
//colibase.bham.ac.uk/) to access the different databases and
for comparison of the G4C operon region in different ge-
nomes.
RESULTS
Etk and Etp are required for capsule formation by EPEC.
Homologs of Etk (YccC) and Etp (YccY) are frequently in-
volved in capsule formation (17, 31, 33). We, therefore, tested
the role of Etk and Etp in capsule formation by EPEC O127:
H6. A common definition of the E. coli capsule is “a heat-
sensitive structure that interferes with bacterial agglutination
upon incubation with anti-O antibody” (12, 13). We, therefore,
used the agglutination test to compare wild-type EPEC with
the etp::kan and etk::kan mutants. The titer of the anti-O127
antiserum required to agglutinate the etp and etk mutants was
16-fold lower than that required to agglutinate the wild-type
EPEC (Table 3). This indicates that LPS is masked by a cap-
sule in the wild type but not in the mutants. LPS masking was
removed upon heat destruction of the capsule (Table 3).
Complementation with plasmids expressing etk or etp (pOI277
and pAP2064, respectively) restored the LPS-masking effect.
TABLE 3. Agglutination with anti-O127 antibody of wild-type
EPEC O127, etk::kan and etp::kan mutants, and mutants
complemented with plasmids carrying wild-type etk or etp alleles
Inactivated/complementing gene Anti-O127 titera
Wild type................................................................................ 4 (64)
etk::kan ................................................................................... 64 (128)
etk::kan/etk.............................................................................. 8 (32)
etp::kan................................................................................. 64 (64)
etp::kan/etp ........................................................................... 8 (64)
a The titer is the reciprocal value of the highest antiserum dilution causing
agglutination. The values obtained after removing the capsule by heating for 2
min at 100°C are in parentheses.
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Taken together, these results indicate that Etk and Etp are
required for capsule formation by EPEC.
To further support this notion, we examined the bacteria by
transmission electron microscopy, following staining with cat-
ionized ferritin. A thick layer of ferritin-stained material was
seen at the surface of most (80.5%) of the wild-type bacteria,
although this layer was not always uniformly dense over the
bacterial surface (Fig. 1C). The appearance of the etk mutant
complemented with plasmid expressing etk was similar to that
of the wild type (77.5% encapsulated bacteria), whereas very
few etk::kan mutants were stained with ferritin (8%). In the
latter case, the staining was sparse and generally appeared
filamentous, suggesting that the ferritin might be staining a
glycosylated surface pilus structure rather than capsular mate-
rial. Colonies of heavily encapsulated bacteria are usually mu-
coid. In contrast, the wild-type EPEC, as well as the etp and etk
mutants, exhibited a nonmucoid colony morphology. Differ-
ences in bacterial buoyancy on a Percoll step density gradient
were exploited to detect capsules that do not produce mucoid
colonies (16). Using this assay, we found that the EPEC
etk::kan mutant exhibited a lower buoyancy than did the wild-
type strain (Fig. 1B). The buoyancy of the etk mutant was
restored upon complementation with a plasmid expressing etk.
Similar results were obtained using the EPEC etp mutant (data
not shown). These findings support the notion that etk and etp
are required for capsule formation.
The CA operon is not required for production of the Etk-
dependent capsule. We identified in the EPEC genome data-
base two gene clusters encoding enzymes required for polysac-
charide biosynthesis. One is the CA biosynthesis operon, and
downstream of it resides the LPS O side chain biosynthesis
region. To test the possible involvement of the CA operon in
the formation of the etk/etp-dependent capsule, we deleted the
CA operon promoter region and part of the operon’s first gene
(wza). To confirm inactivation of the CA operon, we intro-
duced into the mutant (MS1651) and into wild-type EPEC a
plasmid overexpressing RcsA, a regulator that activates expres-
sion of the CA operon (14). As expected, RcsA-expressing
EPEC, grown in LB at 37°C, produced mucoid colonies, but
strain MS1651 lost this ability upon RcsA overexpression (data
not shown). In contrast, the buoyancy of this mutant was sim-
ilar to that of wild-type EPEC when grown in LB at 37°C.
These results indicate that the CA operon is not required for
the production of the etp/etk-dependent capsule. It also sug-
gests that etp and etk may be involved in the formation of G4C,
composed of polymers similar to those of the O side chain
polysaccharide.
Etp and Etk are required for the formation of G4C. Some E.
coli strains of serogroups O127 and O111 form G4C, which is
composed of a polysaccharide similar to that of the LPS O side
chain (13, 27). G4C polymers extracted from these strains
reacted with anti-O antibody, but the encapsulated O111 bac-
teria do not undergo agglutination by anti-O111 antibodies
(13). To investigate whether Etp and Etk are involved in the
production of G4C, the capsule and LPS of EPEC strain
E2348/69, serogroup O127, were extracted and separated by
differential centrifugation and phase partition (24, 27). SDS-
PAGE and Western blotting with anti-O127 were used to as-
sess the amount of LPS side chain without the possible inter-
ference of the capsular polysaccharide, which cannot enter the
gel because of its low net charge and high molecular weight
(13, 27, 34) (Fig. 2A). The purified capsular polysaccharide was
analyzed by immuno-dot blot assay with anti-O127 (Fig. 2B).
We found that anti-O127 antibody reacted with the purified
capsular polysaccharide, indicating that this is an O-antigen
capsule. We also found that synthesis of the capsular polysac-
charide was abolished upon inactivation of etk or etp and was
associated with increased synthesis of the LPS O side chain
(Fig. 2A and B). Introduction of complementing plasmids par-
tially restored capsule production, which was associated with a
reduction in LPS O side chain synthesis (Fig. 2A and B). These
results indicate that etp and etk are required for the assembly
of G4C and are consistent with the hypothesis that the capsule
synthesis system and the LPS O side chain synthesis system are
competing for the same repeat-unit precursor (27). Some
strains producing G4C are sensitive to complement; spontane-
ous variants, deficient in capsule formation, exhibit increased
O-antigen synthesis, which may lead to changes in O-antigen
conformation (12, 18, 19). These changes in O-antigen synthe-
sis correlated with increased bacterial complement resistance
(12, 18, 19). Given our previous results, we predicted that the
etk mutant would be complement resistant. To test this hypoth-
esis, cultures in early logarithmic growth phase were mixed
with fresh human serum and survival was monitored. The hu-
man serum rapidly killed wild-type EPEC (Fig. 2C), but the
EPEC etk::kan mutant was barely affected. Complementation
with plasmid expressing etk partially restored complement sen-
sitivity. Inactivation of the complement by heat treatment abol-
FIG. 1. Expression of Etk and its relation to buoyant density and
capsule formation. Bacterial proteins were extracted and used for
immunoblotting to which an anti-Etk antibody was applied (A). Etk is
expressed by wild-type EPEC (lane 1) and by the EPEC etk::kan
mutant complemented with a plasmid expressing etk (lane 3), but not
by the EPEC etk::kan mutant (lane 2). The bacterial buoyancy assay is
shown in panel B. Bacteria were grown to an OD600 of 0.3, and 5 ml of
the cultures was underlaid with 2 ml Percoll in a transparent tube and
centrifuged. Wild-type EPEC (tube 1) and an etk::kan mutant contain-
ing a plasmid expressing etk (tube 3) appear at the Percoll-medium
interface (arrow), whereas the etk::kan cells (tube 2) form a pellet.
Panel C shows electron microscopy images of the Etk-dependent cap-
sule formed by EPEC O127. The etk::kan mutant appears noncapsu-
lated, whereas the wild-type strain and the etk::kan mutant comple-
mented with an etk-expressing plasmid form capsules (indicated by
arrows).
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ished the serum’s ability to kill the bacteria (Fig. 2C). The
tested serum did not contain anticapsule antibody (data not
shown), excluding the possibility that the complement was spe-
cifically recruited to the encapsulated bacteria by anticapsule
antibodies. These results indicate that in EPEC O127 the in-
terplay between G4C and LPS synthesis is similar to that de-
scribed for E. coli O111 (12).
The G4C operon. To identify additional genes involved in
capsule formation, we screened a mini-Tn10 mutant library
and isolated an EPEC mutant, SN40, which exhibits decreased
buoyancy in the Percoll buoyancy assay. The mini-Tn10 inser-
tion site in SN40 was mapped to ymcA, a gene located three
open reading frames upstream of etk (Fig. 3A). Western anal-
ysis showed that SN40 does not produce Etk (Fig. 4A), nor is
Etk production restored upon complementation with ymcA-
expressing plasmid (data not shown). These results indicate
that the mini-Tn10 insertion in SN40 introduced a polar effect
and suggest that ymcA and etk are encoded within an operon
FIG. 2. Etk and Etp are required for synthesis of G4C. Total poly-
saccharides (LPS and capsular polysaccharide) were extracted, and the
capsular polysaccharide was separated from the LPS. Production of
LPS O antigen was analyzed by Western blotting (A), and the amount
of purified capsular polysaccharide was estimated by dot blot assay (B).
In both cases, care was taken to apply amounts of material equivalent
to the same amount of bacteria in all the lanes. The Western blot and
the dot blots were developed with anti-O127 antiserum. The genotypes
of the analyzed strains are indicated above the lanes. The etk::kan and
the etp::Cm mutants did not produce capsules (B) but synthesized
greater amounts of the LPS side chain (A). Complementation of the
mutants with plasmids expressing etk or etp partially restored capsule
production (B) and reduced synthesis of the LPS side chain (A). Panel
C shows the resistance of the etk::kan mutant to complement-mediated
killing. Early-log cultures were incubated with fresh or inactivated
human serum. Wild-type EPEC cells were killed rapidly by the fresh
serum (line 1) but not by the heat-inactivated serum (line 4). The
EPEC etk::kan mutant (line 3) was highly resistant to fresh serum;
complementation of the mutant with plasmid expressing etk (line 2)
resulted in a partial increase in serum sensitivity. All experiments were
carried out in triplicate, and the standard error is indicated.
FIG. 3. The G4C operon. Schematic of the G4C operon and flank-
ing genes (cspH and appA) (A). The location of the G4C operon
promoter is indicated by an arrow. Mapping of the G4C promoter (B).
Total RNA was extracted from exponential- and stationary-phase
EPEC cultures (OD600 of 0.3 and 1, respectively). Primer extension
analysis (3 g, total RNA) of the ymcD promoter region and the
sequencing reaction were carried out using the same primer. Plasmid
pAP2133 served as a template for the sequencing reaction. The tran-
scription start site was mapped to a G residue located 166 bases
upstream of the ymcD translation start site. In panel C, Western
analysis with anti-Etk antibody was used to compare wild-type EPEC
with strain AD2119, in which a polar cassette between ymcD and the
promoter was inserted. The polar insertion abolished Etk expression,
confirming that ymcD through etk are expressed by the same transcrip-
tional unit.
FIG. 4. Inactivation of each of the G4C operon genes results in
lack of buoyancy on a Percoll step gradient. Each of the G4C operon
genes was inactivated. To confirm nonpolarity, expression of Etk by the
different mutants was determined using Western blot analysis with
anti-Etk antibody (A). The genotype of the tested EPEC is indicated
above each lane. SN40 is an EPEC strain containing a mini-Tn10kan
polar insertion in ymcA. The wild-type strain is indicated as EPEC.
Below the blot, the results of the buoyancy assays using the corre-
sponding mutants (B) and the mutants complemented with plasmid
expressing the corresponding gene (C) are shown. Buoyancy on Percoll
is indicated as a plus sign, lack of buoyancy is indicated as a minus sign,
and a slash indicates that buoyancy was not tested.
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containing seven genes: ymcD, ymcC, ymcB, ymcA, yccZ, etp,
and etk (Fig. 3A). To test this prediction, we performed prim-
er-extension analysis of RNA extracted from EPEC, using a
primer complementing the ymcD mRNA (Fig. 3). A transcrip-
tion start site was localized to a G residue located 166 bp
upstream of the ymcD translation start site (Fig. 3B). To test
whether this is the only promoter of the G4C operon, we
inserted a suicide plasmid, which served as a polar cassette,
between the G4C promoter and ymcD. The insertion abolished
the production of Etk (Fig. 3C), confirming that ymcD and etk
are the first and last genes, respectively, of the G4C operon.
All the genes in the G4C operon are required for capsule
formation. We next introduced a nonpolar mutation into each
of the G4C operon genes and confirmed the lack of polarity by
Western analysis, using anti-Etk antibody (Fig. 4A). All the
mutants proved to be deficient in capsule formation, as deter-
mined by the buoyancy assay (Fig. 4B). We then cloned each of
the G4C genes in the pSA10 expression vector (Table 1) and
used these plasmids in complementation assays. Capsule pro-
duction was restored by complementation with plasmids ex-
pressing the corresponding genes (Fig. 4C). These results in-
dicate that each of the seven proteins encoded by the operon
is required for G4C formation.
The G4C operon in different E. coli and Shigella sp. strains.
Using genomic databases, we compared the chromosomal re-
gion containing the G4C operon with the corresponding region
in several E. coli and Shigella sp. strains. We found an intact
G4C operon in seven genomes. These include EPEC O127
strain E2348/69; two EHEC strains, EDL933 and Sakai; and
three Shigella strains, S. sonnei 53G, S. flexneri strains 2a 301
and 2a 2457T, and S. dysenteriae M131649. These E. coli and
Shigella strains are expected to form G4C. Intact G4C operons
were found also in two E. coli K-12 strains, MG1655 and
W3110. But in both cases the promoter was inactivated by an
IS1 element inserted 15 bp upstream of the ymcD translation
start site, a finding that explains the lack of etk expression in
these E. coli K-12 strains (17, 31). The entire G4C operon is
absent from uropathogenic E. coli strain CFT073 and from
enteroaggregative E. coli strain 042.
DISCUSSION
E. coli employs several alternative mechanisms to synthesize
the O side chain, of which the Wzy-dependent pathway is used
also for synthesis of the G4C polymers (1, 32). In this report we
describe the identification and characterization of an operon
containing seven genes that are required for G4C formation.
Thus, the genes required for G4C formation are organized in
two separate operons. One operon contains genes required for
the Wzy-dependent synthesis of the O side chain and the G4C
polymers. The other, the G4C operon, is required for secretion
of the G4C polymers and for capsule assembly. The G4C
operon is conserved between different E. coli serogroups, in-
dicating that the encoded secretion apparatus is not specific to
the cognate O polymers. Wzy-dependent O-antigen synthesis
requires Wzy, the O side chain polymerase (2), and WaaL,
which ligates the polymerized O antigen to the core oligosac-
charide (28). The Wzz protein is required for determination of
O side chain length, which is typically 15 to 25 repeat units (7,
11). It has been speculated that Wzy, WaaL, and Wzz are
components in an O side chain synthesis complex (28). We are
currently testing the hypothesis that the products of the G4C
operon form a complex that competes with the O side chain
synthesis complex for the repeat unit precursor. The G4C
operon encodes seven proteins: Etk, Etp, YzzZ, YmcA, YmcB,
YmcC, and YmcD. Etk, Etp, and YccZ are similar to Wzc,
Wzb, and Wza, respectively, which are required for secretion
of polysaccharide including colanic acid and of K30 polymers
(9, 31, 35). Members of the Etk protein family are inner mem-
brane proteins possessing two transmembrane helices and tend
to oligomerize (8, 26). They are composed of three distinct
domains: a short cytoplasmic N-terminal domain, a large
periplasmic loop, and a large C-terminal cytoplasmic domain
(8). Since the periplasmic domains of Etk and Wzz show some
similarity, we are currently testing whether Etk uses its Wzz-
like domain to recruit the Wzy to the G4C complex and to
modulate it to polymerize very long capsular O polymers. The
C-terminal domain of Etk and related proteins contains a
protein tyrosine kinase catalytic site. These proteins undergo
autophosphorylation at several conserved tyrosines clustered
at the C terminus. The phosphorylation is essential for secre-
tion of the cognate polysaccharides (26, 31, 35). An additional,
minor substrate of Wzc is Ugd (UDP-glucose dehydrogenase)
(15). Etk was reported also to phosphorylate RpoH and RseA
(anti-RpoE) (20), and therefore, it might also be involved in
genetic regulation. Etp is a low-molecular-weight protein ty-
rosine phosphatase (31). It is predicted to reside in the cyto-
plasm and mediate Etk dephosphorylation both in vitro and in
vivo (reference 31 and our unpublished results). We speculate
that Etp and Etk might energize the G4C assembly system by
repeated phosphorylation and dephosphorylation of the Etk
C-terminal cytoplasmic domain. YccZ is an outer membrane
lipoprotein. Octamers of Wza-K30, and probably also of other
Wza-like proteins, including YccZ, form pore-like structures in
the outer membrane (3, 9). It is believed that the polysaccha-
rides are delivered to the surface via these pores (3, 9). We
predict, therefore, that the G4C polymer is secreted via the
YccZ channel. Based on their deduced sequence, YmcA,
YmcB, YmcC, and YmcD contain an N-terminal signal se-
quence and should be exported proteins. Two of them, YmcA
and YmcC, are putative lipoproteins. YmcB appears to reside
in the periplasm in a soluble form or is associated with the
inner or outer membrane. YmcD is a small protein containing
two putative transmembrane domains. It is unusually rich in
threonine: 28 of its 107 residues are threonines. E. coli contains
paralogs of the ymcABCD genes, the yjbHGFE genes, which
form a putative operon localized in the xylE malG region. The
function of the yjbHGFE genes is unknown. Interestingly,
Vibrio cholerae O139 contains homologs of the ymcABC genes,
the otnGFE genes (4). The function of these genes has not
been determined, but they are located in the vicinity of otnAB,
which are transcribed in the opposite direction and required
for the formation of the O139 capsule (4).
In conclusion, we here identify seven genes required for
G4C formation by EPEC O127. We recently found that all the
tested EPEC serotypes, including O111, O119, O142, and O55,
and the closely related enterohemorrhagic E. coli serotype
O157, form G4C and/or express Etk (reference 17 and unpub-
lished data). This correlation suggests that G4C may play a role
in the virulence of these closely related pathogens. We are now
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testing this hypothesis. G4C might also be involved in the
virulence of Shigella strains containing intact G4C operons.
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